ID   HI
AC   CVCL_A1GY
DR   Wikidata; Q102114126
RX   DOI=10.5282/edoc.3898;
RX   PubMed=9384677;
RX   PubMed=15706405;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
RX   DOI=10.5282/edoc.3898;
RA   Euer N.I.;
RT   "Identification of target genes for the therapy and diagnosis of
RT   ovarian carcinoma.";
RL   Thesis PhD (2005); Ludwig Maximilians University of Munich; Munich; Germany.
//
RX   PubMed=9384677;
RA   Guckel B., Lindauer M., Rudy W., Habicht A., Siebels M., Kaul S.,
RA   Bastert G., Meuer S.C., Moebius U.;
RT   "CD80-transfected human breast and ovarian tumor cell lines: improved
RT   immunogenicity and induction of cytolytic CD8+ T lymphocytes.";
RL   Cytokines Mol. Ther. 1:211-221(1995).
//
RX   PubMed=15706405; DOI=10.3892/or.13.3.375;
RA   Euer N.I., Kaul S., Deissler H., Mobus V.J., Zeillinger R.,
RA   Weidle U.H.;
RT   "Identification of L1CAM, Jagged2 and neuromedin U as ovarian
RT   cancer-associated antigens.";
RL   Oncol. Rep. 13:375-387(2005).
//